Update: 13.12.2021
Last week: 48th week 2021 (29.11.2021 - 05.12.2021)
Last full month: Nov 2021
| Time period | Volume | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. |
|---|---|---|---|---|---|---|---|---|
| APILAC | ||||||||
| WoW | 1 728 | 0.6% | 46.8% | 2.4 | 757 840 | 1.0% | 76.7% | 2 |
| MoM | 7 959 | -19.1% | 47.1% | -5.7 | 3 472 255 | -18.8% | 76.7% | -3.8 |
| YTD | 110 703 | -23.7% | 56.4% | -5.4 | 42 598 268 | 0.5% | 80.6% | 0.1 |
| MAT | 122 293 | -23.1% | 56.8% | -4.8 | 46 443 025 | 0.3% | 80.7% | 0.4 |
| CAPSICAM | ||||||||
| WoW | 22 971 | 5.1% | 3.9% | 0.3 | 9 313 355 | 5.4% | 4.1% | 0.4 |
| MoM | 95 769 | -2.9% | 3.5% | 0.3 | 38 687 899 | -3.0% | 3.7% | 0.3 |
| YTD | 968 981 | -20.0% | 3.1% | -0.3 | 399 844 476 | -5.4% | 3.4% | -0.2 |
| MAT | 1 086 106 | -19.1% | 3.2% | -0.3 | 448 507 438 | -3.2% | 3.5% | -0.1 |
| MILDRONATE | ||||||||
| WoW | 96 677 | -4.3% | 12.1% | 0.1 | 37 459 941 | -3.9% | 17.4% | 0 |
| MoM | 452 608 | -4.7% | 12.5% | -0.2 | 173 520 666 | -5.0% | 17.3% | 0.2 |
| YTD | 4 425 797 | 14.4% | 9.3% | 1.4 | 1 789 537 353 | 21.3% | 14.1% | 2.4 |
| MAT | 4 841 100 | 15.4% | 9.1% | 1.3 | 1 965 618 686 | 23.3% | 14.1% | 2.3 |
| SULFARGIN | ||||||||
| WoW | 3 263 | 16.2% | 1.0% | 0.2 | 1 593 361 | 12.7% | 1.4% | 0.2 |
| MoM | 12 818 | -5.2% | 0.9% | 0 | 6 444 451 | -5.0% | 1.3% | 0 |
| YTD | 148 087 | -23.9% | 0.8% | -0.2 | 72 007 260 | -10.3% | 1.2% | -0.1 |
| MAT | 162 877 | -21.5% | 0.8% | -0.2 | 78 869 157 | -7.5% | 1.2% | -0.1 |
| VIPROSAL | ||||||||
| WoW | 29 393 | 2.1% | 4.9% | 0.3 | 11 416 024 | 3.8% | 5.1% | 0.4 |
| MoM | 141 907 | -0.9% | 5.2% | 0.5 | 54 642 364 | 1.6% | 5.3% | 0.6 |
| YTD | 1 119 653 | -14.6% | 3.6% | -0.1 | 421 995 294 | -4.6% | 3.6% | -0.1 |
| MAT | 1 233 904 | -14.1% | 3.6% | -0.1 | 466 197 003 | -2.6% | 3.7% | -0.1 |
| Brand | Volume | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. |
|---|---|---|---|---|---|---|---|---|
| APILAC | 1 728 | 0.6% | 46.8% | 2.4 | 757 840 | 1.0% | 76.7% | 2 |
| CAPSICAM | 22 971 | 5.1% | 3.9% | 0.3 | 9 313 355 | 5.4% | 4.1% | 0.4 |
| MILDRONATE | 96 677 | -4.3% | 12.1% | 0.1 | 37 459 941 | -3.9% | 17.4% | 0 |
| SULFARGIN | 3 263 | 16.2% | 1.0% | 0.2 | 1 593 361 | 12.7% | 1.4% | 0.2 |
| VIPROSAL | 29 393 | 2.1% | 4.9% | 0.3 | 11 416 024 | 3.8% | 5.1% | 0.4 |
| Brand | Volume | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. |
|---|---|---|---|---|---|---|---|---|
| APILAC | 7 959 | -19.1% | 47.1% | -5.7 | 3 472 255 | -18.8% | 76.7% | -3.8 |
| CAPSICAM | 95 769 | -2.9% | 3.5% | 0.3 | 38 687 899 | -3.0% | 3.7% | 0.3 |
| MILDRONATE | 452 608 | -4.7% | 12.5% | -0.2 | 173 520 666 | -5.0% | 17.3% | 0.2 |
| SULFARGIN | 12 818 | -5.2% | 0.9% | 0 | 6 444 451 | -5.0% | 1.3% | 0 |
| VIPROSAL | 141 907 | -0.9% | 5.2% | 0.5 | 54 642 364 | 1.6% | 5.3% | 0.6 |
| Brand | Volume | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. |
|---|---|---|---|---|---|---|---|---|
| APILAC | 110 703 | -23.7% | 56.4% | -5.4 | 42 598 268 | 0.5% | 80.6% | 0.1 |
| CAPSICAM | 968 981 | -20.0% | 3.1% | -0.3 | 399 844 476 | -5.4% | 3.4% | -0.2 |
| MILDRONATE | 4 425 797 | 14.4% | 9.3% | 1.4 | 1 789 537 353 | 21.3% | 14.1% | 2.4 |
| SULFARGIN | 148 087 | -23.9% | 0.8% | -0.2 | 72 007 260 | -10.3% | 1.2% | -0.1 |
| VIPROSAL | 1 119 653 | -14.6% | 3.6% | -0.1 | 421 995 294 | -4.6% | 3.6% | -0.1 |
| Brand | Volume | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. |
|---|---|---|---|---|---|---|---|---|
| APILAC | 122 293 | -23.1% | 56.8% | -4.8 | 46 443 025 | 0.3% | 80.7% | 0.4 |
| CAPSICAM | 1 086 106 | -19.1% | 3.2% | -0.3 | 448 507 438 | -3.2% | 3.5% | -0.1 |
| MILDRONATE | 4 841 100 | 15.4% | 9.1% | 1.3 | 1 965 618 686 | 23.3% | 14.1% | 2.3 |
| SULFARGIN | 162 877 | -21.5% | 0.8% | -0.2 | 78 869 157 | -7.5% | 1.2% | -0.1 |
| VIPROSAL | 1 233 904 | -14.1% | 3.6% | -0.1 | 466 197 003 | -2.6% | 3.7% | -0.1 |
## [1] "VIPROSAL"## [1] "VIPROSAL B UNGUENT FOR EXT USE 30 G #1"## [1] "VIPROSAL B UNGUENT FOR EXT USE 50 G #1"## [1] "VIPROSAL B UNGUENT FOR EXT USE 75 G #1"## [1] "VIPROSAL"## [1] "VIPROSAL B UNGUENT FOR EXT USE 30 G #1"## [1] "VIPROSAL B UNGUENT FOR EXT USE 50 G #1"## [1] "VIPROSAL B UNGUENT FOR EXT USE 75 G #1"## [1] "CAPSICAM"## [1] "CAPSICAM UNGUENT FOR EXT USE 30 G #1"## [1] "CAPSICAM UNGUENT FOR EXT USE 50 G #1"## [1] "CAPSICAM"## [1] "CAPSICAM UNGUENT FOR EXT USE 30 G #1"## [1] "CAPSICAM UNGUENT FOR EXT USE 50 G #1"## [1] "MILDRONATE"## [1] "MILDRONATE CAPS 250 MG #40"## [1] "MILDRONATE CAPS 500 MG #60"## [1] "MILDRONATE"## [1] "MILDRONATE CAPS 250 MG #40"## [1] "MILDRONATE CAPS 500 MG #60"## [1] "SULFARGIN"## [1] "SULFARGIN UNGUENT FOR EXT USE 1% 15 G #1"## [1] "SULFARGIN UNGUENT FOR EXT USE 1% 50 G #1"## [1] "SULFARGIN"## [1] "SULFARGIN UNGUENT FOR EXT USE 1% 15 G #1"## [1] "SULFARGIN UNGUENT FOR EXT USE 1% 50 G #1"## [1] "APILAC"## [1] "APILAC TABS 10 MG #25"## [1] "APILAC TABS 10 MG #50"## [1] "APILAC"## [1] "APILAC TABS 10 MG #25"## [1] "APILAC TABS 10 MG #50"Data Sources:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs